Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Debt / NOTE 1.750% 6/1
-
Market price (% of par)
-
91.39%
-
Total 13F principal
-
$329,642,811
-
Principal change
-
+$2,765,170
-
Total reported market value
-
$301,007,000
-
Number of holders
-
41
-
Value change
-
+$6,235,211
-
Number of buys
-
20
-
Number of sells
-
18
Institutional Holders of ACORDA THERAPEUTICS INC - NOTE 1.750% 6/1 as of Q1 2018
As of 31 Mar 2018,
ACORDA THERAPEUTICS INC - NOTE 1.750% 6/1 was held by
41 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$329,642,811
in principal (par value) of the bond.
The largest 10 bondholders included
CITADEL ADVISORS LLC, CANYON CAPITAL ADVISORS LLC, WOLVERINE ASSET MANAGEMENT LLC, Partner Fund Management, L.P., CNH PARTNERS LLC, Davidson Kempner Capital Management LP, CREDIT SUISSE AG/, SILVERBACK ASSET MANAGEMENT LLC, Jefferies Group LLC, and AMERIPRISE FINANCIAL INC.
This page lists
42
institutional bondholders reporting positions
for the Q1 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.